ClinicalTrials.Veeva

Menu

Supermicrosurgical Lymphvenous Bypass Intervention for Treatment

Chang Gung Medical Foundation logo

Chang Gung Medical Foundation

Status

Unknown

Conditions

Lymphedema of Leg

Treatments

Other: Antegrade and retrograde anastomoses
Other: Antegrade-only anastomoses

Study type

Observational

Funder types

Other

Identifiers

NCT05270629
202101384B0

Details and patient eligibility

About

Background: In addition to antegrade anastomosis, retrograde anastomosis has been thought to offer further improvements after lymphaticovenous anastomosis (LVA) by bypassing the retrograde lymphatic flow. However, this concept has yet to be validated. The aim of this study was to determine the impacts on outcomes of performing both retrograde and antegrade anastomosis, as compared to antegrade-only anastomosis for treating lower limb lymphedema.

Enrollment

87 estimated patients

Sex

All

Ages

18 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Lower limb lymphedema patients.

Exclusion criteria

  • Patients who have had previous LVA, liposuction, or excisional therapy such as the Charles procedure were excluded.

Trial design

87 participants in 1 patient group

Lower limb lymphedema patients
Description:
This was a retrospective cohort propensity score-matched study. Patients with lower limb lymphedema were enrolled.
Treatment:
Other: Antegrade-only anastomoses
Other: Antegrade and retrograde anastomoses

Trial contacts and locations

1

Loading...

Central trial contact

Ching-Hua Hsieh, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems